Results for tag: "Oncophage"

Oncophage is a type of cancer vaccine developed to treat certain types of cancer. It is designed to stimulate the body's immune system to recognize and attack cancer cells. Oncophage is a personalized cancer vaccine, meaning it is tailored to the individual patient's tumor. It is made from a sample of the patient's tumor, which is then processed to create a vaccine that is specific to the patient's cancer. Oncophage is currently being studied in clinical trials for the treatment of several types of cancer, including melanoma, prostate cancer, and pancreatic cancer. The goal of these trials is to determine the safety and efficacy of Oncophage in treating these cancers. Oncophage is a promising new treatment option for cancer patients, offering the potential for personalized, targeted treatment. It is an exciting development in the field of cancer vaccines, and could potentially revolutionize the way cancer is treated. Some companies in the Oncophage market include Antigen Express, Inc., OncoVax, Inc., and OncoImmunity, Inc. Show Less Read more